Kat Kayser-Bricker

Kat Kayser-Bricker is an accomplished chemist with extensive experience in scientific leadership and portfolio strategy. Currently serving as Chief Scientific Officer and Senior Director at Halda Therapeutics since May 2019, Kat also holds board positions at Modifi Bio and BioCT. Prior board membership includes the Humanity Talent Network. Kat's past roles at FORMA Therapeutics involved directing early discovery chemistry and leading automated synthesis efforts. Academic training culminated in a PhD in Chemistry from Yale University, following a BS in Chemistry from the University of Maryland. Kat's research contributions include advancements in synthetic methodology and natural product synthesis.